← Back to Search

Intrauterine Device

Mona Lisa® NT Cu380 Mini for Birth Control

Phase 3
Waitlist Available
Research Sponsored by Kimberly Myer
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights

Summary

This trial tests two types of copper IUDs in women eligible for IUD use to compare their effectiveness and safety. Copper IUDs work by releasing copper ions that prevent sperm from fertilizing an egg. The TCu 380A (Paragard) is a widely used copper IUD known for its safety and effectiveness.

Eligible Conditions
  • Healthy Women
  • Birth Control

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 5 years for reporting.

Treatment Details

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Mona Lisa® NT Cu380 MiniExperimental Treatment1 Intervention
Mona Lisa® NT Cu380 Mini containing 380mm2 of copper surface inserted into the uterine cavity.
Group II: ParaGard® CuT380AActive Control1 Intervention
ParaGard® CuT380A containing 380mm2 of copper surface inserted into the uterine cavity.

Find a Location

Who is running the clinical trial?

Kimberly MyerLead Sponsor
FHI 360OTHER
100 Previous Clinical Trials
300,377 Total Patients Enrolled
Health DecisionsLead Sponsor
30 Previous Clinical Trials
12,897 Total Patients Enrolled
~121 spots leftby Sep 2025